Drug Trial Radar · NCT02976675
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
Last checked: Nov 20, 2026Latest source record: Jun 16, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
600
Planned (sponsor's estimate)
Start
Jan 2015
Primary completion
Jun 2017
Sponsor
- Lead sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Children's Hospital of Fudan University; Suzhou Municipal Hospital; General Hospital of Ningxia Medical University; The First Affiliated Hospital of Henan University of Science and Technology; Maternal and Child Health Hospital of Hubei Province; Nantong University
- First posted
- Nov 29, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 3 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of PEG Somatropin Injection in the treatment of children with growth hormone deficiency, as well as to study the feasibility of extending the dosing intervals (once per two weeks) of PEG Somatropin Injection.
Conditions
- Growth Hormone Deficiency
Interventions
PEG-somatropinBiological
Pegylated somatropin, injection, 54IU/9.0mg/1.0ml/bottle Group of dosing per week:0.20 mg /kg/w, once per week for 26 weeks
PEG-somatropinBiological
Pegylated somatropin, injection, 54IU/9.0mg/1.0ml/bottle Group of dosing per two weeks:0.20 mg /kg/2w,once per two weeks for 26 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ht SDScaTime frame: Baseline, 4,12,26 weeks after initiating treatment
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Jishuitan Hospital of Beijing City
Beijing, China · Recruiting
Peoples' hospital of Inner Mongolia Autonomous Region
Inner Mongolia Autonomous Region, China · Recruiting
General Hospital of Ningxia Medical University
Ningxia Autonomous Region, China · Recruiting
Children's Hospital of Fudan University
Shanghai, China · Recruiting
Maternal and Child Health Hospital of Anhui province
Hefei, Anhui, China · Recruiting
First People's Hospital of Lu'an City
Lu'an, Anhui, China · Recruiting
Second Hospital of Lanzhou University
Lanzhou, Gansu, China · Recruiting
Maternal and Child Health Hospital of Guiyang City
Guiyangtou, Guizhou, China · Recruiting
Maternal and Child Health Hospital of Hainan province
Haikou, Hainan, China · Recruiting
Hebei Provincial People's Hospital
Shijiazhuang, Hebei, China · Recruiting
First Affiliated Hospital of Henan University of Science and Technology
Zhengzhou, Henan, China · Recruiting
Maternal and Child Health Hospital of Hubei province
Wuhan, Hubei, China · Recruiting
First People's Hospital of Changzhou City
Changzhou, Jiangsu, China · Recruiting
First People's Hospital of Lianyungang City
Lianyungang, Jiangsu, China · Recruiting
Jiangsu Provincial Hospital of Chinese Traditional medicine
Nanjingkou, Jiangsu, China · Recruiting
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China · Recruiting
Suzhou City Hospital
Suzhou, Jiangsu, China · Recruiting
Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
Maternal and Child Health Hospital of Tai'an city
Tai’an, Shandong, China · Recruiting
Children's Hospital of Chengdu city
Chengdu, Sichuan, China · Recruiting
People's Hospital of Cixi City
Cixi, Zhejiang, China · Recruiting
First People's Hospital
Hangzhou, Zhejiang, China · Recruiting
First People's Hospital of Jiaxing City
Jiaxing, Zhejiang, China · Recruiting
Jinhua Central Hospital
Jinhua, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.